Novel compound heterozygote mutations in the ATP7B gene in an Iranian family with Wilson disease: A case report

被引：8

作者：

Daneshjoo O. ^{[1
,3
]}

Garshasbi M. ^{[2
,3
]}

机构：

[1] Department of Molecular and Cell Biology, Nano and Biotechnology Research Group, Faculty of Basic Sciences, University of Mazandaran, Babolsar

[2] Department of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran

[3] Medical Genetics Department, DeNA Laboratory, Tehran

来源：

Journal of Medical Case Reports | / 12卷 / 1期

关键词：

ATP7B gene; Compound heterozygote; Sequencing; Wilson disease;

D O I：

10.1186/s13256-018-1608-0

中图分类号：

学科分类号：

摘要：

Background: Wilson disease is an autosomal recessive disorder of copper transport and is characterized by excessive accumulation of cellular copper in the liver and other tissues because of impaired biliary copper excretion and disturbed incorporation of copper into ceruloplasmin. Hepatic failure and neuronal degeneration are the major symptoms of Wilson disease. Mutations in the ATP7B gene are the major cause of Wilson disease. Case presentation: In this study we have screened one pedigree with several affected members, including a 24-year-old Iranian woman and a 20-year-old Iranian man, who showed psychiatric and neurological symptoms of varying severity, by amplifying the coding regions including exon-intron boundaries with polymerase chain reaction and sequencing. We identified c.1924G>C and c.3809A>G mutations in affected members as compound heterozygote state. These mutations segregated with the disease in the family and they were absent in a cohort of 100 Iranian ethnicity-matched healthy controls. Conclusions: No homozygote state has been reported for these two variants in public databases. In silico predicting tools consider these two variants to be damaging. So this study introduces the novel combination of c.1924G>C and c.3809A>G variants as a cause for Wilson disease. © 2018 The Author(s).

引用

共 23 条

[1]

Oe S., Miyagawa K., Honma Y., Harada M., Copper induces hepatocyte injury due to the endoplasmic reticulum stress in cultured cells and patients with Wilson disease, Exp Cell Res., 347, 1, pp. 192-200, (2016)

[2]

Kinnier Wilson S.A., Progressive lenticular degeneration: A familial nervous disease associated with cirrhosis of the liver, Lancet., 179, 4626, pp. 1115-1119, (1912)

[3]

Kaler S., Packman S., Inherited Disorders of Human Copper Metabolism, Emery and Rimoin's Principles and Practice of Medical Genetics, pp. 1-21, (2013)

[4]

Wang L.-C., Wang J.-D., Tsai C.-R., Cheng S.-B., Clinical Features L.C.-C., Therapeutic Response in Taiwanese Children with Wilson's Disease: 12 Years of Experience in a Single Center, Pediatr Neonatol., 51, 2, pp. 124-129, (2010)

[5]

Iida M., Terada K., Sambongi Y., Wakabayashi T., Miura N., Koyama K., Futai M., Sugiyama T., Analysis of functional domains of Wilson disease protein (ATP7B) in Saccharomyces cerevisiae, FEBS Lett., 428, 3, pp. 281-285, (1998)

[6]

Simsek O., Asik S., Cakmur R., Terzioglu O., European Journal of Medical Genetics Mutation analysis of ATP7B gene in Turkish Wilson disease patients: Identification of five novel mutations, Eur J Med Genet., 56, 4, pp. 175-179, (2013)

[7]

Huster D., Finegold M.J., Morgan C.T., Burkhead J.L., Nixon R., Vanderwerf S.M., Gilliam C.T., Lutsenko S., Consequences of Copper Accumulation in the Livers of the Atp7b-/- (Wilson Disease Gene) Knockout Mice, Am J Pathol., 168, 2, pp. 423-434, (2006)

[8]

Wang H., Cheng N., Dong J., Wang X., Han Y., Yang R., Han Y., Serum pentraxin 3 is elevated in patients with neurological Wilson's disease, Clin Chim Acta., 462, pp. 178-182, (2016)

[9]

DiDonato M., Sarkar B., Copper transport and its alterations in Menkes and Wilson diseases, Biochim Biophys Acta Mol Basis Dis., 1360, 1, pp. 3-16, (1997)

[10]

Van Den Berghe P.V.E., Stapelbroek J.M., Krieger E., De Bie P., Van De Graaf S.F.J., De Groot R.E.A., Van Beurden E., Spijker E., Houwen R.H.J., Berger R., Klomp L.W.J., Reduced expression of ATP7B affected by Wilson disease-causing mutations is rescued by pharmacological folding chaperones 4-phenylbutyrate and curcumin, Hepatology., 50, 6, pp. 1783-1795, (2009)

← 1 2 3 →